vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and CHART INDUSTRIES INC (GTLS). Click either name above to swap in a different company.

CHART INDUSTRIES INC is the larger business by last-quarter revenue ($1.1B vs $749.2M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). CHART INDUSTRIES INC runs the higher net margin — 5.0% vs 3.6%, a 1.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -2.5%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 6.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.

CLOV vs GTLS — Head-to-Head

Bigger by revenue
GTLS
GTLS
1.4× larger
GTLS
$1.1B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+64.5% gap
CLOV
62.0%
-2.5%
GTLS
Higher net margin
GTLS
GTLS
1.3% more per $
GTLS
5.0%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
6.6%
GTLS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
GTLS
GTLS
Revenue
$749.2M
$1.1B
Net Profit
$27.3M
$53.6M
Gross Margin
33.3%
Operating Margin
3.6%
11.6%
Net Margin
3.6%
5.0%
Revenue YoY
62.0%
-2.5%
Net Profit YoY
-32.7%
EPS (diluted)
$0.05
$1.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GTLS
GTLS
Q1 26
$749.2M
Q4 25
$487.7M
$1.1B
Q3 25
$496.6M
$1.1B
Q2 25
$477.6M
$1.1B
Q1 25
$462.3M
$1.0B
Q4 24
$337.0M
$1.1B
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
$1.0B
Net Profit
CLOV
CLOV
GTLS
GTLS
Q1 26
$27.3M
Q4 25
$-49.3M
$53.6M
Q3 25
$-24.4M
$-138.5M
Q2 25
$-10.6M
$76.1M
Q1 25
$-1.3M
$49.5M
Q4 24
$-22.1M
$79.6M
Q3 24
$-9.2M
$69.0M
Q2 24
$7.4M
$58.6M
Gross Margin
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
33.3%
Q3 25
34.1%
Q2 25
33.6%
Q1 25
33.9%
Q4 24
33.6%
Q3 24
24.5%
34.1%
Q2 24
30.3%
33.8%
Operating Margin
CLOV
CLOV
GTLS
GTLS
Q1 26
3.6%
Q4 25
-10.1%
11.6%
Q3 25
-4.9%
-8.0%
Q2 25
-2.2%
15.7%
Q1 25
-0.3%
15.2%
Q4 24
-6.4%
17.0%
Q3 24
-2.7%
16.8%
Q2 24
2.0%
16.1%
Net Margin
CLOV
CLOV
GTLS
GTLS
Q1 26
3.6%
Q4 25
-10.1%
5.0%
Q3 25
-4.9%
-12.6%
Q2 25
-2.2%
7.0%
Q1 25
-0.3%
4.9%
Q4 24
-6.6%
7.2%
Q3 24
-2.8%
6.5%
Q2 24
2.1%
5.6%
EPS (diluted)
CLOV
CLOV
GTLS
GTLS
Q1 26
$0.05
Q4 25
$1.06
Q3 25
$-3.23
Q2 25
$1.53
Q1 25
$0.94
Q4 24
$1.57
Q3 24
$1.33
Q2 24
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GTLS
GTLS
Cash + ST InvestmentsLiquidity on hand
$177.6M
$366.0M
Total DebtLower is stronger
$3.7B
Stockholders' EquityBook value
$339.4M
$3.2B
Total Assets
$697.7M
$9.8B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GTLS
GTLS
Q1 26
$177.6M
Q4 25
$78.3M
$366.0M
Q3 25
$399.2M
Q2 25
$342.3M
Q1 25
$296.2M
Q4 24
$194.5M
$308.6M
Q3 24
$288.0M
$310.2M
Q2 24
$254.8M
$247.4M
Total Debt
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
$3.7B
Q3 25
Q2 25
Q1 25
Q4 24
$3.8B
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
GTLS
GTLS
Q1 26
$339.4M
Q4 25
$308.7M
$3.2B
Q3 25
$340.9M
$3.2B
Q2 25
$344.2M
$3.4B
Q1 25
$336.1M
$3.0B
Q4 24
$341.1M
$2.8B
Q3 24
$342.2M
$3.0B
Q2 24
$324.9M
$2.7B
Total Assets
CLOV
CLOV
GTLS
GTLS
Q1 26
$697.7M
Q4 25
$541.0M
$9.8B
Q3 25
$559.7M
$9.8B
Q2 25
$575.0M
$9.7B
Q1 25
$583.7M
$9.3B
Q4 24
$580.7M
$9.1B
Q3 24
$653.0M
$9.5B
Q2 24
$674.2M
$9.3B
Debt / Equity
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
1.13×
Q3 25
Q2 25
Q1 25
Q4 24
1.33×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GTLS
GTLS
Operating Cash FlowLast quarter
$88.8M
Free Cash FlowOCF − Capex
$66.2M
FCF MarginFCF / Revenue
6.1%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
1.66×
TTM Free Cash FlowTrailing 4 quarters
$202.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
$-66.9M
$88.8M
Q3 25
$12.1M
$118.0M
Q2 25
$5.4M
$145.9M
Q1 25
$-16.3M
$-60.0M
Q4 24
$34.8M
$281.4M
Q3 24
$50.0M
$200.6M
Q2 24
$44.8M
$116.1M
Free Cash Flow
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
$-69.0M
$66.2M
Q3 25
$11.4M
$94.7M
Q2 25
$4.8M
$122.0M
Q1 25
$-16.5M
$-80.1M
Q4 24
$33.3M
$260.9M
Q3 24
$49.6M
$174.5M
Q2 24
$44.4M
$88.0M
FCF Margin
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
-14.1%
6.1%
Q3 25
2.3%
8.6%
Q2 25
1.0%
11.3%
Q1 25
-3.6%
-8.0%
Q4 24
9.9%
23.6%
Q3 24
15.0%
16.4%
Q2 24
12.5%
8.5%
Capex Intensity
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
0.4%
2.1%
Q3 25
0.1%
2.1%
Q2 25
0.1%
2.2%
Q1 25
0.0%
2.0%
Q4 24
0.5%
1.9%
Q3 24
0.1%
2.5%
Q2 24
0.1%
2.7%
Cash Conversion
CLOV
CLOV
GTLS
GTLS
Q1 26
Q4 25
1.66×
Q3 25
Q2 25
1.92×
Q1 25
-1.21×
Q4 24
3.54×
Q3 24
2.91×
Q2 24
6.04×
1.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GTLS
GTLS

Repair Service And Leasing Segment$330.4M31%
Heat Transfer Systems Segment$325.8M30%
Specialty Products Segment$259.5M24%
Transferred Over Time$94.4M9%
Transferred At Point In Time$69.5M6%

Related Comparisons